Skip to main content


The global pharmacogenomics market is expected to grow significantly over the forecast period. This is due to the growing demand for personalized medicine, advancements in genetic research, and the increasing incidence of chronic diseases. The rise in genetic tests and growing awareness about pharmacogenomics among healthcare professionals and patients are also contributing to the market growth.